[1] Krizkova S, Kepinska M, Emri G, et al. Microarray analysis of metallothioneins in human diseases-A review [J]. J Pharmaceut Biomed, 2015, 117(1):8-20.[2] Barbieux C, Bacharouche J, Soussen C, et al. DDB2 (damaged-DNA binding 2) protein: a new modulator of nanomechanical properties and cell adhesion of breast cancer cells [J]. Nanoscale, 2016, 8(9):5268-5279.[3] Zhang XX, Chen WW, She B, et al. The efficacy and safety of Jian-Wei-Qu-Tong Pills for the treatment of chronic non-atrophic gastritis (spleen and stomach qi deficiency with damp-heat stasis syndrome): study protocol for a phase Ⅱ, randomized controlled trial [J]. Trials, 2014, 15(1):1-11.[4] 郭宇丹.辛开苦降法治疗寒热错杂型非萎缩性胃炎的临床研究[D].北京:北京中医药大学,2014.[5] 潘军伟,卢俊明.调和肝脾法治疗慢性非萎缩性胃炎45例[J].浙江中医杂志,2015,50(8):578.[6] 陈余妍.慢性非萎缩性胃炎中医证候与幽门螺杆菌感染相关性的研究[D].北京:北京中医药大学,2013.[7] Noto JM, Peek RM. Helicobacter pylori: an overview [J]. Methods Mol Biol, 2012, 921:7-10.[8] Wang F, Meng W, Wang B, et al. Helicobacter pylori-induced gastric inflammation and gastric cancer [J]. Cancer Lett, 2014, 345(2):196-202.[9] 王 丹.标准三联疗法联合清胃止痛微丸治疗幽门螺杆菌相关慢性胃炎的疗效[J].中华消化杂志,2013,33(11):772-775.[10] 王 放.清胃止痛微丸体外抑制幽门螺旋杆菌的实验研究[A].山东省第十次消化病学会议暨第七次消化内镜学术会议论文汇编[C]. 山东:济南,2012.[11] 刘安楠,孙铁英.炎性体在炎症反应中的调节作用[J].生理学报,2012,64(6): 741-750.[12] De Nardo D, De Nardo CM, Latz E. New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease [J]. Am J Pathol, 2014, 184(1):42-54.[13] Chen IY, Ichinohe T. Response of host inflammasomes to viral infection [J]. Trends Microbiol, 2015, 23(1):55-63.[14] Ermler ME, Traylor Z, Patel K, et al. Rift valley fever virus infection induces activation of the NLRP3 inflammasome [J]. Virology, 2014, 449(449):174-180.[15] 段 云.痘疹样胃炎根除幽门螺杆菌前后100例临床疗效分析[J].中国实用内科杂志,2015,35(增1):152-153. |